Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
220
-
Total 13F shares, excl. options
-
13.9M
-
Shares change
-
+561K
-
Total reported value, excl. options
-
$3.36B
-
Value change
-
+$106M
-
Put/Call ratio
-
0.31
-
Number of buys
-
140
-
Number of sells
-
-85
-
Price
-
$242.26
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q1 2023
290 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q1 2023.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 220 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.9M shares
of 22.2M outstanding shares and own 62.41% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (1.67M shares), BAKER BROS. ADVISORS LP (1.55M shares), VANGUARD GROUP INC (1.42M shares), BlackRock Inc. (953K shares), PERCEPTIVE ADVISORS LLC (651K shares), MARSHALL WACE, LLP (542K shares), STATE STREET CORP (520K shares), Assenagon Asset Management S.A. (517K shares), JANUS HENDERSON GROUP PLC (376K shares), and Rock Springs Capital Management LP (348K shares).
This table shows the top 220 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.